JP4540667B2 - 抗真菌性ネイルコート - Google Patents

抗真菌性ネイルコート Download PDF

Info

Publication number
JP4540667B2
JP4540667B2 JP2006507422A JP2006507422A JP4540667B2 JP 4540667 B2 JP4540667 B2 JP 4540667B2 JP 2006507422 A JP2006507422 A JP 2006507422A JP 2006507422 A JP2006507422 A JP 2006507422A JP 4540667 B2 JP4540667 B2 JP 4540667B2
Authority
JP
Japan
Prior art keywords
nail
antifungal
composition
weight
terbinafine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2006507422A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006520800A (ja
Inventor
ケプカ，スタンリー・ダブリユ
モー・ワイ，ジヨージフ
ワン，ハン−ヨン
ルー，ミンチ
フイスター，ウイリアム・アール
Original Assignee
ネクスメツド・ホールデイングス・インコーポレイテツド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ネクスメツド・ホールデイングス・インコーポレイテツド filed Critical ネクスメツド・ホールデイングス・インコーポレイテツド
Publication of JP2006520800A publication Critical patent/JP2006520800A/ja
Application granted granted Critical
Publication of JP4540667B2 publication Critical patent/JP4540667B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/41—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7015—Drug-containing film-forming compositions, e.g. spray-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q3/00—Manicure or pedicure preparations
    • A61Q3/02—Nail coatings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/806—Drug, bio-affecting and body treating compositions involving IgM
    • Y10S424/807—Monoclonal
    • Y10S424/808—Human

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Emergency Medicine (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
JP2006507422A 2003-03-21 2004-03-22 抗真菌性ネイルコート Expired - Fee Related JP4540667B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US45668403P 2003-03-21 2003-03-21
US60/456,684 2003-03-21
PCT/US2004/008618 WO2004084826A2 (en) 2003-03-21 2004-03-22 Antifungal nail coat and method of use

Publications (2)

Publication Number Publication Date
JP2006520800A JP2006520800A (ja) 2006-09-14
JP4540667B2 true JP4540667B2 (ja) 2010-09-08

Family

ID=33098141

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006507422A Expired - Fee Related JP4540667B2 (ja) 2003-03-21 2004-03-22 抗真菌性ネイルコート

Country Status (28)

Country Link
US (3) US7462362B2 (de)
EP (2) EP2106805B1 (de)
JP (1) JP4540667B2 (de)
KR (1) KR101093990B1 (de)
CN (2) CN102973420A (de)
AT (2) ATE432087T1 (de)
AU (1) AU2004224326B2 (de)
BR (1) BRPI0408613A (de)
CA (1) CA2519705C (de)
CO (1) CO5640092A2 (de)
CY (1) CY1111773T1 (de)
DE (1) DE602004021253D1 (de)
DK (2) DK2106805T3 (de)
EC (1) ECSP056110A (de)
ES (1) ES2366273T3 (de)
HR (1) HRP20050918A2 (de)
IL (1) IL170963A (de)
IS (1) IS8078A (de)
MA (1) MA27760A1 (de)
MX (1) MXPA05010114A (de)
NO (1) NO335895B1 (de)
NZ (1) NZ542904A (de)
PL (1) PL2106805T3 (de)
RU (1) RU2358718C2 (de)
SG (1) SG152065A1 (de)
TN (1) TNSN05231A1 (de)
WO (1) WO2004084826A2 (de)
ZA (1) ZA200507972B (de)

Families Citing this family (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050238672A1 (en) * 2004-04-27 2005-10-27 Nimni Marcel E Antifungal drug delivery
US20060275230A1 (en) * 2004-12-10 2006-12-07 Frank Kochinke Compositions and methods for treating conditions of the nail unit
EP2295036A2 (de) * 2004-12-10 2011-03-16 Talima Therapeutics, Inc. Flüssige Zusammensetzungen und Verfahren zur Behandlung von Nagelstörungen
EP1698336A1 (de) * 2005-03-01 2006-09-06 Ferrer Internacional, S.A. Antimykotischezusammensetzungen enthaltend Sertaconazol und entweder Hydrokortison oder einen antibakteriellen Wikrstoff
FR2892023B1 (fr) * 2005-10-14 2009-09-25 Galderma Sa Composition pharmaceutique a base d'amorolfine et d'agent filmogene hydrosoluble pour application ungueale et peri-ungueale
US20080299060A1 (en) * 2006-01-02 2008-12-04 Tlt Medical Ltd. Pharmaceutical Composition for the Treatment of Nail Diseases
WO2007098591A2 (en) * 2006-03-02 2007-09-07 Nuvo Research Inc. Topical nail formulation
JP5184342B2 (ja) 2006-03-08 2013-04-17 日本農薬株式会社 外用の医薬組成物
BRPI0621446C1 (pt) 2006-03-08 2021-05-25 Nihon Nohyaku Co Ltd composição farmacêutica para uso externo
KR101373955B1 (ko) * 2006-03-08 2014-03-12 니혼노야쿠가부시키가이샤 외용의 의약 조성물
EP2191827B1 (de) 2007-09-05 2013-10-30 Pola Pharma Inc. Antimykotische zusammensetzung
CN101808639B (zh) 2007-09-05 2012-12-05 宝丽制药股份有限公司 抗真菌医药组合物
CN101808637B (zh) 2007-09-05 2013-07-24 宝丽制药股份有限公司 医药组合物
US20090175810A1 (en) 2008-01-03 2009-07-09 Gareth Winckle Compositions and methods for treating diseases of the nail
RU2526162C2 (ru) 2008-10-03 2014-08-20 Нексмед Холдингз, Инк. Стабилизированная композиция для лечения псориаза
EP2361083A4 (de) * 2008-10-21 2013-11-20 Novodermix Internat Ltd Zusammensetzung zur behandlung von epithelgewebe
WO2010047288A1 (en) 2008-10-24 2010-04-29 Semiconductor Energy Laboratory Co., Ltd. Method for manufacturing semiconductordevice
WO2010065936A1 (en) * 2008-12-04 2010-06-10 Chongxi Yu High penetration compositions and their applications
US20100291182A1 (en) * 2009-01-21 2010-11-18 Arsenal Medical, Inc. Drug-Loaded Fibers
WO2010086727A1 (en) * 2009-01-30 2010-08-05 Galderma Pharma Sa Stable compositions for nail onychomycosis treatment
EP2391344B1 (de) * 2009-01-30 2017-07-12 Yissum Research Development Company of the Hebrew University of Jerusalem Zusammensetzung zur nagel- und hautbehandlung
US10130610B2 (en) 2009-04-09 2018-11-20 Pola Pharma Inc. Antimycotic pharmaceutical composition
KR101409792B1 (ko) 2009-04-09 2014-06-19 니혼노야쿠가부시키가이샤 항진균성 약제학적 조성물
WO2011014850A2 (en) 2009-07-31 2011-02-03 Nuvo Research Inc. Topical eutectic-based formulations
US12544491B2 (en) 2009-08-24 2026-02-10 Arsenal Medical, Inc. In situ forming hemostatic foam implants
US9173817B2 (en) 2009-08-24 2015-11-03 Arsenal Medical, Inc. In situ forming hemostatic foam implants
US20110202016A1 (en) * 2009-08-24 2011-08-18 Arsenal Medical, Inc. Systems and methods relating to polymer foams
US10420862B2 (en) 2009-08-24 2019-09-24 Aresenal AAA, LLC. In-situ forming foams for treatment of aneurysms
US9044580B2 (en) 2009-08-24 2015-06-02 Arsenal Medical, Inc. In-situ forming foams with outer layer
WO2011024620A1 (en) 2009-08-25 2011-03-03 Pola Pharma Inc. Antimycotic pharmaceutical composition
EP2522336A4 (de) * 2009-11-02 2014-08-27 Fukumotogiken Corp Co Ltd Hautkosmetik-knetzusammensetzung und verfahren zu ihrer herstellung sowie verfahren zur verwendung der hautkosmetik-knetzusammensetzung
EP2544659A2 (de) * 2009-12-23 2013-01-16 Nuvo Research Inc. Terbinafinformulierung zur behandlung von nagelpilz mit hohem durchdringungsgrad
CN102858158A (zh) * 2010-05-04 2013-01-02 尼克美控股公司 小分子治疗剂的组合物
SG10201600228QA (en) * 2010-05-04 2016-03-30 Nexmed Holdings Inc Therapeutic peptide composition and method
US8039494B1 (en) 2010-07-08 2011-10-18 Dow Pharmaceutical Sciences, Inc. Compositions and methods for treating diseases of the nail
RU2432158C1 (ru) * 2010-07-28 2011-10-27 Закрытое акционерное общество "Институт прикладной нанотехнологии" Профилактический бактерицидный лак для обработки ногтей
EP2646015B1 (de) * 2010-12-02 2020-04-22 Ferring International Center S.A. Aktives enantiomer aus dodecyl-2-(n,n-dimethylamino)-propionat
US8968626B2 (en) 2011-01-31 2015-03-03 Arsenal Medical, Inc. Electrospinning process for manufacture of multi-layered structures
US9034240B2 (en) 2011-01-31 2015-05-19 Arsenal Medical, Inc. Electrospinning process for fiber manufacture
US9194058B2 (en) 2011-01-31 2015-11-24 Arsenal Medical, Inc. Electrospinning process for manufacture of multi-layered structures
RU2013144975A (ru) * 2011-04-08 2015-05-20 Пфайзер Инк. Кристаллические и некристаллические формы тофацитиниба и фармацевтическая композиция, содержащая тофацитиниб, и усилитель проникновения
MX345458B (es) * 2011-05-11 2017-02-01 Veloce Biopharma Llc Composiciones antimicoticas para el tratamiento de piel y uñas.
CA2745320A1 (en) 2011-07-06 2013-01-06 Duoject Medical Systems Inc. Reconstitution device
US8993831B2 (en) 2011-11-01 2015-03-31 Arsenal Medical, Inc. Foam and delivery system for treatment of postpartum hemorrhage
JP6122035B2 (ja) * 2012-02-17 2017-04-26 ヴェローチェ・バイオファーマ・エルエルシー 皮膚および爪の治療のための抗真菌組成物
CA2775393C (en) * 2012-05-02 2014-04-29 Samy Saad Topical non-aqueous pharmaceutical formulations
JP6124892B2 (ja) 2012-07-30 2017-05-10 Ｍｅｉｊｉ Ｓｅｉｋａファルマ株式会社 抗白癬菌症貼付剤
CN104661661A (zh) * 2012-07-30 2015-05-27 明治制果药业株式会社 抗白癣菌症外用液剂
US8900625B2 (en) * 2012-12-15 2014-12-02 Nexmed Holdings, Inc. Antimicrobial compounds and methods of use
US8697753B1 (en) 2013-02-07 2014-04-15 Polichem Sa Method of treating onychomycosis
CA2904703A1 (en) 2013-03-14 2014-10-02 Hallux, Inc. Method of treating infections, diseases or disorders of nail unit
US20140271529A1 (en) * 2013-03-14 2014-09-18 Alc Therapeutics, Llc Antifungal compositions for the treatment of secondary skin and nail infections
GB201317005D0 (en) * 2013-09-25 2013-11-06 Blueberry Therapeutics Ltd Composition and methods of treatment
SG11201602596UA (en) 2013-10-03 2016-04-28 Dow Pharmaceutical Sciences Stabilized efinaconazole compositions
KR102612453B1 (ko) 2013-11-22 2023-12-08 다우 파마슈티컬 사이언시즈, 인코포레이티드 항­감염 방법，조성물，및 장치
EP2952208A1 (de) * 2014-06-04 2015-12-09 Universidade de Santiago de Compostela Hydroalkoholisches System zur Nagelbehandlung
CN106573892B (zh) 2014-08-13 2019-10-25 明治制果药业株式会社 结晶性抗白癣菌药及其制备方法
JP6280675B1 (ja) 2015-01-20 2018-02-14 ヴェローチェ・バイオファーマ・エルエルシー 新規ヨードフォア組成物および使用方法
JP6591100B1 (ja) * 2019-01-25 2019-10-16 ロート製薬株式会社 爪及び爪周り用医薬組成物
CN112791048B (zh) * 2020-12-31 2023-01-17 海南海神同洲制药有限公司 一种硝酸舍他康唑栓及其制备方法

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3069633D1 (en) 1979-08-22 1984-12-20 Sandoz Ag Propenylamines, processes for their production, pharmaceutical compositions containing them and their use as pharmaceuticals
DE3045914A1 (de) 1980-12-05 1982-07-22 Bayer Ag, 5090 Leverkusen Antimykotische mittel mit hoher wirkstoff-freisetzung in form von elastischen fluessig-pflastern
US4406509A (en) * 1981-11-25 1983-09-27 E. I. Du Pont De Nemours & Co. Jack and plug electrical assembly
DE3544983A1 (de) 1985-12-19 1987-06-25 Hoechst Ag Antimykotisch wirksamer nagellack
US4861764A (en) 1986-11-17 1989-08-29 Macro Chem. Corp. Percutaneous absorption enhancers, compositions containing same and method of use
FR2613227B1 (fr) * 1987-04-01 1990-12-28 Oreal Compositions pharmaceutiques a base de nitrate de miconazole ou de nitrate d'econazole dans le traitement des infections fongiques des ongles
US4980378A (en) 1988-06-01 1990-12-25 Odontex, Inc. Biodegradable absorption enhancers
US5082866A (en) * 1988-06-01 1992-01-21 Odontex, Inc. Biodegradable absorption enhancers
FR2673537B1 (fr) * 1991-03-08 1993-06-11 Oreal Utilisation d'agents de penetration hydrophiles dans les compositions dermatologiques pour le traitement des onychomycoses, et compositions correspondantes.
HU219480B (hu) * 1991-05-23 2001-04-28 Novartis Ag. Eljárás gombás körömmegbetegségek ellen helyileg alkalmazható, allil-amin-származékot tartalmazó gyógyászati készítmények előállítására
ATE285212T1 (de) * 1993-10-07 2005-01-15 Odontex Inc Absorptionsförderer für topische pharmazeutische formulierungen
US6019988A (en) * 1996-11-18 2000-02-01 Bristol-Myers Squibb Company Methods and compositions for enhancing skin permeation of drugs using permeation enhancers, when drugs and/or permeation enhancers are unstable in combination during long-term storage
US6046244A (en) * 1997-11-05 2000-04-04 Nexmed Holdings, Inc. Topical compositions for prostaglandin E1 delivery
RU2141854C1 (ru) * 1998-11-25 1999-11-27 Закрытое акционерное общество "Интермед" Способ лечения грибковых заболеваний ногтей
US6118020A (en) 1999-05-19 2000-09-12 Nexmed Holdings, Inc. Crystalline salts of dodecyl 2-(N,N-dimethylamino)-propionate
US6495124B1 (en) * 2000-02-14 2002-12-17 Macrochem Corporation Antifungal nail lacquer and method using same
KR20080049148A (ko) * 2000-02-16 2008-06-03 벤트레이 파마슈티칼스, 인코포레이티드 약학적 조성물
US7074392B1 (en) 2000-03-27 2006-07-11 Taro Pharmaceutical Industries Limited Controllled delivery system of antifungal and keratolytic agents for local treatment of fungal infections
AU2000255769A1 (en) * 2000-07-01 2002-01-14 Chemtech Research Incorporation Process for preparation of terbinafine and its hydrochloride as an antifungal agent
JP4899139B2 (ja) * 2000-08-10 2012-03-21 株式会社ポーラファルマ 抗真菌医薬組成物
JP4803511B2 (ja) * 2000-08-25 2011-10-26 株式会社ポーラファルマ 抗真菌医薬組成物
JP2002068975A (ja) * 2000-08-25 2002-03-08 Pola Chem Ind Inc 抗真菌医薬組成物
US6585963B1 (en) * 2001-02-15 2003-07-01 Watson Pharmaceuticals, Inc. Nail compositions and methods of administering same
US6846837B2 (en) * 2002-06-21 2005-01-25 Howard I. Maibach Topical administration of basic antifungal compositions to treat fungal infections of the nails

Also Published As

Publication number Publication date
HRP20050918A2 (en) 2006-12-31
KR20060003868A (ko) 2006-01-11
MA27760A1 (fr) 2006-02-01
CO5640092A2 (es) 2006-05-31
SG152065A1 (en) 2009-05-29
EP1635770A2 (de) 2006-03-22
NZ542904A (en) 2009-04-30
DK1635770T3 (da) 2009-08-03
EP1635770A4 (de) 2007-12-26
NO20054830L (no) 2005-12-16
BRPI0408613A (pt) 2006-03-07
ES2366273T3 (es) 2011-10-18
ATE512672T1 (de) 2011-07-15
DK2106805T3 (da) 2011-08-15
WO2004084826A3 (en) 2004-11-04
ATE432087T1 (de) 2009-06-15
NO20054830D0 (no) 2005-10-19
CA2519705A1 (en) 2004-10-07
US20130323189A1 (en) 2013-12-05
ECSP056110A (es) 2006-03-01
CA2519705C (en) 2013-07-02
US7462362B2 (en) 2008-12-09
CN102973420A (zh) 2013-03-20
MXPA05010114A (es) 2006-04-27
CY1111773T1 (el) 2015-10-07
TNSN05231A1 (fr) 2007-06-11
IL170963A (en) 2010-12-30
CN1791378A (zh) 2006-06-21
KR101093990B1 (ko) 2011-12-16
RU2358718C2 (ru) 2009-06-20
AU2004224326B2 (en) 2010-04-22
NO335895B1 (no) 2015-03-16
US20090099266A1 (en) 2009-04-16
IS8078A (is) 2005-10-18
ZA200507972B (en) 2007-02-28
RU2005132390A (ru) 2006-06-27
US20060067898A1 (en) 2006-03-30
AU2004224326A1 (en) 2004-10-07
EP2106805B1 (de) 2011-06-15
PL2106805T3 (pl) 2011-10-31
EP2106805A1 (de) 2009-10-07
DE602004021253D1 (de) 2009-07-09
EP1635770B1 (de) 2009-05-27
WO2004084826A2 (en) 2004-10-07
JP2006520800A (ja) 2006-09-14

Similar Documents

Publication Publication Date Title
JP4540667B2 (ja) 抗真菌性ネイルコート
US6143794A (en) Topical formulations for the treatment of nail fungal diseases
US6846837B2 (en) Topical administration of basic antifungal compositions to treat fungal infections of the nails
JP6307203B1 (ja) 皮膚および爪の治療のための抗真菌組成物
US20110020474A1 (en) Methods of Treating Infections of the Nail or Skin Using Hypohalite
JPS5822010B2 (ja) ビヒクル系を含有する局所用製薬担体組成物
JP2015507008A (ja) 皮膚および爪の治療のための抗真菌組成物
JP2007534764A (ja) 抗真菌薬物送達
AU2006298748B2 (en) Antifungal composition
AU2011219546B2 (en) Fungal nail treatment composition
HK1179898A (en) Antifungal nail coat and method of use
HK1093020A (en) Antifungal nail coat and method of use
RU2575774C2 (ru) Композиция для лечения грибка ногтей
US20050123491A1 (en) Composition and method for treating onychomycosis
MX2008004132A (en) Antifungal composition

Legal Events

Date Code Title Description
A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20091104

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20100128

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20100204

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20100427

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20100601

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20100622

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130702

Year of fee payment: 3

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees